Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Gaceta médica de México
versión On-line ISSN 2696-1288versión impresa ISSN 0016-3813
Resumen
RAMOS-PRUDENCIO, Rubí; LOZANO-RUIZ, Francisco; RODRIGUEZ-LAGUNA, Alejandro y ADELA POITEVIN-CHACON, María. Current uses and applications of stereotactic body radiation therapy. Gac. Méd. Méx [online]. 2023, vol.159, n.3, pp.268-275. Epub 12-Jun-2023. ISSN 2696-1288. https://doi.org/10.24875/gmm.22000412.
Stereotactic body radiation therapy (SBRT) is a modality that delivers high doses of radiation to a well-defined tumor target in a single or a few fractions and with high precision, which significantly reduces the dose received by surrounding normal tissues. SBRT is indicated for inoperable, early stage (T1 and T2) primary non-small cell lung cancer, lung metastases with a controlled primary tumor, prostate tumors and oligometastatic disease. Despite the lack of long-term or phase III studies, efficacy results in local control are higher than 90%, with similar toxicity to that reported with conventional fractionated radiotherapy. This article describes SBRT technology and technique, along with clinical applications, indications and limitations of this therapeutic modality.
Palabras llave : Oligometastases; Radiosurgery; Stereotactic body radiosurgery.